Maximize your thought leadership

Private Label CBD Gummies Market to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Manufacturing

By FisherVista
The private label CBD gummies market is projected to grow from $646.2 million in 2026 to $1.38 billion by 2036, driven by wellness brands outsourcing production to reduce costs and accelerate time-to-market.
Private Label CBD Gummies Market to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Manufacturing

The private label CBD gummies market is set to expand significantly over the next decade, with projections indicating a rise from $646.2 million in 2026 to $1.38 billion by 2036, according to a new report from Future Market Insights (FMI). The market, valued at $598.9 million in 2025, is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2036.

Market growth is being fueled by wellness brands increasingly opting for outsourced manufacturing to avoid the high costs and complexities of building their own production facilities. By partnering with contract manufacturers, companies can launch private label or white label CBD gummies more quickly and with lower capital investment. This trend is particularly pronounced as competition intensifies in the functional wellness industry.

White label gummies are leading the service model segment, accounting for 46.2% of global demand in 2026. These ready-made formulations allow brands to focus on marketing and customer acquisition rather than product development. Broad-spectrum CBD gummies are the dominant spectrum type, capturing 42.8% of the market, driven by consumer preference for THC-free products that still offer multiple cannabinoids.

Brand websites are the leading sales channel, representing 39.6% of global demand in 2026, as direct-to-consumer platforms enable better customer education and subscription-based purchasing. The United States is the fastest-growing market, with a projected CAGR of 8.5% through 2036, supported by a mature CBD ecosystem and a strong direct-to-consumer infrastructure.

Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., CV Sciences, Inc., Medterra CBD LLC, British Cannabis, Cannaray Limited, MediPharm Labs Corp., and Little Green Pharma Ltd. These companies are competing on formulation expertise, manufacturing scalability, and compliance support.

For more detailed market forecasts and competitive benchmarking, visit Future Market Insights. The full report is available in PDF format at this link.

FisherVista

FisherVista

@fishervista